Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dicle Yurdatap Koç
Observed names:
D. Yurdatap,
Dicle Yurdatap Koc
Institution:
Trakya University
Observed institution:
Trakya University
ORCID:
0000-0002-2573-6634
Observed ORCID:
0000-0002-2573-6634
OpenAlex ID:
A5119529407
Prognostic Value of the Lung Immune Prognostic Index and an ECOG–Albumin–LIPI Nomogram in Metastatic NSCLC Patients Treated with Second- or Third-Line Nivolumab
2026
·
Didem Divriklioğlu
, İsmail Bayrakçı
, et al.
·
Journal of Clinical Medicine
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study
2026
·
Suheda Atas Ipek
, Sendag Yaslikaya
, et al.
·
Journal of Clinical Medicine
PDF
The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma
2026
·
Fahri Akgül
, Süleyman Can
, et al.
·
Medicina
Longer Diagnostic Delay and Post-Diagnosis Overall Survival in a Classic-Kaposi-Sarcoma-Predominant Retrospective Cohort
2026
·
İsmail Bayrakçı
, Didem Divriklioğlu
, et al.
·
Journal of Clinical Medicine
Extra-gastrointestinal stromal tumor of the prostate — a case report and literature review
2025
·
Tayyip İlker Aydın
, Gökhan Öztürk
, et al.
·
Oncology in Clinical Practice
PDF
3005P Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with sorafenib monotherapy: Real-world treatment patterns and clinical outcomes in Türkiye
2025
·
S. Atas Ipek
, I.O. Kara
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
H-index:
I10-index:
Year
Topic
Type
